[1] SUNG H, FERLAY J, SIEGEL RL, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [2] RONGSHOU Z, SIWEI Z, HONGMEI Z, et al.Cancer incidence and mortality in China, 2016[J]. Journal of the National Cancer Center, 2022, 43(5): 702-708. [3] ZHU H, LUO H, ZHANG W, et al.Molecular mechanisms of cisplatin resistance in cervical cancer[J]. Drug Design Development and Therapy, 2016, 10: 1885-1895. [4] GHOSH S.Cisplatin: the first metal based anticancer drug[J]. Bioorganic Chemistry, 2019, 88: 102925. [5] CHEN RL, WANG Z, HUANG P, et al.Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice[J]. International Immunopharmacology, 2021, 94:107357. [6] RASMUSSEN L, ARVIN A.Chemotherapy-induced immun- osuppression[J]. Environmental Health Perspectives, 1982, 43: 21-25. [7] CIANFRONE G, PENTANGELO D, CIANFRONE F, et al.Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide[J]. European Review for Medical and Pharmacological Sciences, 2011, 15(6): 601-636. [8] RIDZUAN NRA, RASHID NA, OTHMAN F, et al.Protective role of natural products in cisplatin-induced nephrotoxicity[J]. Mini-reviews in Medicinal Chemistry, 2019, 19(14): 1134-1143. [9] CHEN X, WEI W, LI YZ, et al.Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis[J]. Chemico-Biological Interactions, 2019, 308: 269-278. [10] CANNA SW, DE JESUS AA, GOUNI S, et al.An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome[J]. Nature Genetics, 2014, 46(10): 1140-1146. [11] ZHANG N, CAI J, XU L, et al.Cisplatin-induced stria vascularis damage is associated with inflammation and fibrosis[J]. Neural Plasticity, 2020, 2020: 8851525. [12] DENG X, LUO S, LUO X, et al.Fraction from lycium barbarum polysaccharides reduces immunotoxicity and enhances antitumor activity of doxorubicin in mice[J]. Integrative Cancer Therapies, 2018, 17(3): 860-866. [13] ZHANG ZJ. Shang Han Lun(伤寒论) [M]. Beijing: China Ancient Books Publishing House, 1997: 35. [14] ZHANG ZJ. Jingui Yaolue Fang(金匮要略方) [M]. Shanghai: Shanghai Scientific and Technological Literature Press, 2011: 93. [15] HUANG JL, HUANG GY, WEI CT, et al.A brief analysis of clinical application of gancao ganjing decoction and its similar prescription[J]. Journal of Practical Traditional Chinese Medicine(实用中医药杂志), 2008(3): 190-191. [16] YAN J.Clinical observation on 20 cases of advanced lung cancer hemoptysis treated with licorice ginger decoction[J]. Liaoning Journal of Traditional Chinese Medicine(辽宁中医杂志), 2006(11): 1443-1444. [17] ZHANG YP, WU N, WANG WY, et al.Experimental study on the role of licorice and dried ginger in treating rats with allergic rhinitis[J]. Journal of Guiyang Medical College(贵阳医学院学报), 2015, 40(1): 36-40. [18] ZHANG QY, WANG FX, JIA KK, et al.Natural product interventions for chemotherapy and radiotherapy-induced side effects[J]. Frontiers in Pharmacology, 2018, 9: 1253. [19] TAN RZ, XIE KH, LIAO Y, et al.Renoprotective effect of isoliquiritigenin on cisplatin-induced acute kidney injury through inhibition of FPR2 in macrophage[J]. Journal of Pharmacological Sciences, 2022, 148(1): 56-64. [20] XIN YM, LIANG HX, SUN ZX.Effectiveness of licorice and dried ginger decoction against mouse breast cancer[J]. Carcinogenesis, Teratogenesis and Mutagenesis(癌变·畸变·突变), 2022, 34(2): 88-92. [21] WANG LX, ZHANG SX, WU HJ, et al.M2b macrophage polarization and its roles in diseases[J]. J Leukoc Biol, 2019, 106(2): 345-358. [22] GALMARINI D, GALMARINI CM, GALMARINI FC.Cancer chemotherapy: a critical analysis of its 60 years of history[J]. Critical Reviews in Oncology/Hematology, 2012, 84(2): 181-199. [23] YANG X, LAM W, JIANG Z, et al.YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment[J]. Scientific Reports, 2021,11(1): 13482. [24] YAO W, BA Q, LI X, et al.A natural CCR2 antagonist relieves tumor-associated macrophage-mediated immunosuppression to produce a therapeutic effect for liver cancer[J]. EBioMedicine, 2017, 22: 58-67. [25] ZHANG QY, WANG FX, JIA KK, et al.Natural product interventions for chemotherapy and radiotherapy-induced side effects[J]. Frontiers in Pharmacology, 2018, 9: 1253. [26] ZAHNG SS, QIN DP, ZHOU Q, et al.Traditional Chinese medicine diagnosis and treatment guide for functional dyspepsia, a common disease of digestive system (grassroots doctor version)[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2019, 34(8): 3619-3625. [27] LI WY, MA SB, WANG X, et al.Research progress of Hanfang Liujunzi Decoction in Japan[J]. Chinese Traditional Patent Medicine(中成药), 2020, 42(8): 2129-2132. [28] WU X, DAI Y, NIE K.Research progress of liujunzi decoction in the treatment of tumor-associated anorexia[J]. Drug Design Development and Therapy, 2022, 16: 1731-1741. [29] CHANGGOU CA, SHIAH HS, CHEN LT, et al.A phase II clinical trial on the combination therapy of PHY906 plus capecitabine in hepatocellular carcinoma[J]. Oncologist, 2021, 26(3): e367-e373. [30] YANG X, LAM W, JIANG Z, et al.YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment[J]. Scientific Reports, 2021, 11(1): 13482. |